Financials data is unavailable for this security.
View more
Year on year QuantumPharm Inc had net income fall 33.08% from a loss of 1.44bn to a larger loss of 1.91bn despite a 30.80% increase in revenues from 133.35m to 174.42m. An increase in the selling, general and administrative costs as a percentage of sales from 207.94% to 224.87% was a component in the falling net income despite rising revenues.
Gross margin | -- |
---|---|
Net profit margin | -1,280.46% |
Operating margin | -345.13% |
Return on assets | -- |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in CNYView more
In 2023, QuantumPharm Inc increased its cash reserves by 23.78%, or 136.54m. Cash Flow from Investing totalled 735.58m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 567.56m for operations while cash used for financing totalled 25.89m.
Cash flow per share | -1.26 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 1.33 |
---|---|
Tangible book value per share | 1.32 |
More ▼
Balance sheet in CNYView more
Current ratio | 15.68 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0397 |
---|---|
Total debt/total capital | 0.038 |
More ▼